These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 17958635)

  • 1. Hepatitis A and B vaccination and public health.
    Hollinger FB; Bell B; Levy-Bruhl D; Shouval D; Wiersma S; Van Damme P
    J Viral Hepat; 2007 Nov; 14 Suppl 1():1-5. PubMed ID: 17958635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination against hepatitis A and B: developments, deployment and delusions.
    Zuckerman JN
    Curr Opin Infect Dis; 2006 Oct; 19(5):456-9. PubMed ID: 16940869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the long-term protection after hepatitis A and B vaccination.
    Van Damme P; Van Herck K
    Travel Med Infect Dis; 2007 Mar; 5(2):79-84. PubMed ID: 17298912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001.
    Van Damme P; Vorsters A
    J Med Virol; 2002 Jul; 67(3):433-9. PubMed ID: 12116040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined vaccine against hepatitis A and B].
    Pawłowska M; Halota W; Kozielewicz D
    Przegl Epidemiol; 2004; 58 Suppl 1():66-70. PubMed ID: 15807160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
    Van Damme P; Van Herck K
    Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public health perspective on vaccine-preventable hepatitis: integrating hepatitis A and B vaccines into public health settings.
    Hershey JH; Schowalter L; Bailey SB
    Am J Med; 2005 Oct; 118 Suppl 10A():100S-108S. PubMed ID: 16271550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of acquiring hepatitis A and B among travelers in selected Eastern and Southern Europe and non-European Mediterranean countries: review and consensus statement on hepatitis A and B vaccination.
    Nothdurft HD; Dahlgren AL; Gallagher EA; Kollaritsch H; Overbosch D; Rummukainen ML; Rendi-Wagner P; Steffen R; Van Damme P;
    J Travel Med; 2007; 14(3):181-7. PubMed ID: 17437475
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis A and B virus immunization in HIV-infected persons.
    Laurence J
    AIDS Read; 2006 Jan; 16(1):15-7. PubMed ID: 16433468
    [No Abstract]   [Full Text] [Related]  

  • 10. The worldwide impact of vaccination on the control and protection of viral hepatitis B.
    Romano' L; Paladini S; Van Damme P; Zanetti AR
    Dig Liver Dis; 2011 Jan; 43 Suppl 1():S2-7. PubMed ID: 21195368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with hepatitis A and B vaccines.
    Davis JP
    Am J Med; 2005 Oct; 118 Suppl 10A():7S-15S. PubMed ID: 16271535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of anti-HAV antibodies in Warsaw population].
    Janaszek-Seydlitz W; Bucholc B; Wiatrzyk A
    Przegl Epidemiol; 2007; 61(4):675-82. PubMed ID: 18572499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The global impact of vaccination against hepatitis B: a historical overview.
    Zanetti AR; Van Damme P; Shouval D
    Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B vaccination strategies tailored to different endemicity levels: some considerations.
    Rots NY; Wijmenga-Monsuur AJ; Luytjes W; Kaaijk P; de Graaf TW; van der Zeijst BA; Boog CJ
    Vaccine; 2010 Jan; 28(4):893-900. PubMed ID: 19932217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of hepatitis A and hepatitis B measures among vaccinated and susceptible online men who have sex with men.
    Gilbert LK; Levandowski BA; Scanlon KE; Peterson RS
    Int J STD AIDS; 2010 Jun; 21(6):400-5. PubMed ID: 20606219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The A's and B's of vaccine-preventable hepatitis: improving prevention in high-risk adults.
    Oldfield EC; Keeffe EB
    Rev Gastroenterol Disord; 2007; 7(1):1-21. PubMed ID: 17392626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination.
    Romanò L; Paladini S; Tagliacarne C; Zappa A; Zanetti AR
    Vaccine; 2009 May; 27(25-26):3439-42. PubMed ID: 19200848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis A and B vaccines].
    Hernández N; Chirino R; Fassio E; Cheinquer H
    Rev Gastroenterol Mex; 2006 Nov; 71 Suppl 2():73-89. PubMed ID: 17465191
    [No Abstract]   [Full Text] [Related]  

  • 19. [Response to hepatitis A and hepatitis B vaccination: genetic differences].
    Degos F
    Gastroenterol Clin Biol; 2003 Apr; 27(4):429-30. PubMed ID: 12759691
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates.
    Jacobs RJ; Rosenthal P; Meyerhoff AS
    Vaccine; 2004 Mar; 22(9-10):1241-8. PubMed ID: 15003653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.